Attached files
Exhibit 32.1
CERTIFICATION
PURSUANT TO 18 U.S.C. SECTION 1350, AS ADOPTED
PURSUANT
TO SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002
In
connection with the report of China Shenghuo Pharmaceutical Holdings, Inc. (the
“Company”) on Form 10-K for the period ending December 31, 2009 as filed
with the Securities and Exchange Commission on the date hereof (the “Report”),
each of the undersigned, in the capacities and on the dates indicated below,
hereby certifies, pursuant to 18 U.S.C. Section 1350, as adopted pursuant
to Section 906 of the Sarbanes-Oxley Act of 2002, that to his
knowledge:
|
(1)
|
The Report fully complies with
the requirements of Section 13(a) or 15(d) of the Securities Exchange Act
of 1934; and
|
|
(2)
|
The information contained in the
Report fairly presents, in all material respects, the financial condition
and results of operations of the
Company.
|
|
/s/
Gui Hua Lan
|
||
|
Gui
Hua Lan
|
||
|
Chief
Executive Officer and Chairman
of
the Board
(Principal
Executive Officer)
April
14, 2010
|
||
|
/s/
Chuanxiang Huang
|
||
|
Chuanxiang
Huang
|
||
|
Chief
Financial Officer
(Principal
Financial and Accounting Officer)
April
14, 2010
|
||